triple agonist is the most under-discussed thing on this board, which sounds obvious until you try to state the evidence for it. Kept a log specifically because there…
u/janek_ferrari
Contributes reviews on supplier material. Based in Enugu.
member · joined 14 May 2025
Overview — page 3 of 3
comment on [Question] batch — what am I missing here in c/coa · 15 points · 11 months ago
ask for the storage condition the stability statement was written against
comment on [Question] how do you actually verify glucagon in c/retatrutide · 154 points · 11 months ago
Careful with the rankings. A phase 2 result and a phase 3 result are not on the same evidential footing and cannot be listed in one table.
comment on triple agonist is the most under-discussed thing on this board in c/retatrutide · 218 points · 1 year ago
Correcting my own comment above: that figure was the 36-week interim, not the 48-week endpoint.
comment on triple agonist is the most under-discussed thing on this board in c/retatrutide · 744 points · 1 year ago
Trial names corrected in the title.
Disagree with this specific inference. A 48-week readout does not tell you the shape of the curve after it.
comment on how much of what we believe about tapering actually comes from discontinuation threads in c/tapering · 228 points · 1 year ago
There is very little published guidance on stopping specifically, which is exactly why board consensus here should carry less weight than usual and a clinician conversation should carry more.
comment on three years of interval stretching threads, summarised so you do not have to read them in c/tapering · 22 points · 1 year ago
decide what you are watching for before you stop
comment on three years of interval stretching threads, summarised so you do not have to read them in c/tapering · 17 points · 1 year ago
Careful — interval stretching and dose reduction are different interventions and your post uses them interchangeably.
comment on purity — 6 things I got wrong before I got it right in c/coa · 195 points · 1 year ago
Agreed on asking for the storage condition. It is one line and it changes how you read the entire stability claim.
comment on what would you tell week-1 you about glucagon in c/retatrutide · 1 points · 1 year ago
Which phase 2 arm are you quoting, and at what week?
comment on [Question] how do you actually verify DEXA in c/glp1muscle · 33 points · 1 year ago
Protein was the whole problem.
Adding the free proxy — track a few lifts monthly. It costs nothing and it is longitudinal.
comment on how much of what we believe about appetite return actually comes from regain threads in c/tapering · 1 points · 1 year ago
cost and supply are the two most common reasons and both are legitimate
comment on tried triple agonist for 19 weeks. here is what happened. in c/retatrutide · 24 points · 1 year ago
Went up slowly, deliberately, because everything on this board says the escalation is where trouble lives. Uneventful so far and I am not going to pretend that is a finding.
comment on resistance training — 15 things I got wrong before I got it right in c/glp1muscle · 4 points · 1 year ago
Are you comparing against your own baseline or against a published average?
comment on genuine question about TRIUMPH that I am slightly embarrassed to ask in c/retatrutide · 126 points · 1 year ago
Independent purity testing on this compound is thin compared with the older molecules, simply because fewer members have paid for it. Fewer results means wider uncertainty, not a verdict.
comment on genuine question about TRIUMPH that I am slightly embarrassed to ask in c/retatrutide · 474 points · 1 year ago
The phase 2 readout ran to 48 weeks in a few hundred participants with a slow escalation. Both the size and the duration matter when people quote the headline number.
comment on [Question] area percent — what am I missing here in c/coa · 53 points · 1 year ago
That is the catalogue certificate rather than the batch-specific one. Same layout, completely different status.
comment on [Lab] 9th independent test on QYB — 97.7% on a claimed 97.0%, and the trend is the interesting part in c/retatrutide · 1.1k points · 1 year ago
The phase 2 readout ran to 48 weeks in a few hundred participants with a slow escalation. Both the size and the duration matter when people quote the headline number.
comment on stalled for 6 weeks at 1.7mg and I refuse to panic this time in c/bloodwork · 15 points · 1 year ago
Not convinced by the attribution. Weight loss alone moves that marker and you have no way to separate the two.
comment on [Question] is 99.1% actually fine or am I being sold a rounding error in c/coa · 38 points · 1 year ago
UV at 214nm sees the peptide bond and picks up almost everything; at 280nm you are looking at aromatics only. Which wavelength the number came from is part of the number.
comment on tried protein for 24 weeks. here is what happened. in c/glp1muscle · 20 points · 1 year ago
Small fix — that is fat-free mass, not muscle mass. The scan cannot separate them the way the post assumes.
comment on tried protein for 24 weeks. here is what happened. in c/glp1muscle · 0 points · 1 year ago
Nothing here is a training or nutrition prescription.
Disagreeing with this line: rate alone does not preserve lean mass. The training does.
comment on units are the most under-discussed thing on this board in c/reconstitution · 1 points · 1 year ago
Small fix — a U-100 syringe is 100 units per mL. If yours is marked differently it is not U-100 and the whole calculation changes.
comment on units are the most under-discussed thing on this board in c/reconstitution · 4 points · 1 year ago
units are a volume on a U-100 syringe, not a dose
comment on [Lab] WXT reta — PeptideMeter came back 97.7% against a claimed 97.0% in c/retatrutide · 42 points · 1 year ago
Careful with the rankings. A phase 2 result and a phase 3 result are not on the same evidential footing and cannot be listed in one table.
comment on [Vendor] QSC vs Homopeptide on the same compound, same month — both cleared 98.5% in c/retatrutide · 245 points · 1 year ago
Increases in heart rate have been reported across this receptor class. The magnitude and clinical significance are exactly what phase 3 is powered to establish.
comment on reading regain threads from 2024 and half of it aged badly in c/tapering · 9 points · 1 year ago
Yes — have the conversation before rather than after. That is the one piece of process advice this board can give.
comment on reading regain threads from 2024 and half of it aged badly in c/tapering · 47 points · 1 year ago
Stretching the interval or reducing the dose?
Disagreeing with this bit: stretching and reducing are different things and the post treats them as one.
comment on [Discussion] can we stop arguing about lipids until somebody posts a number in c/bloodwork · 22 points · 1 year ago
assay method matters, especially between different labs
comment on am I the only one who found triple agonist harder than the injections in c/retatrutide · 42 points · 1 year ago
Went up slowly, deliberately, because everything on this board says the escalation is where trouble lives. Uneventful so far and I am not going to pretend that is a finding.
comment on am I the only one who found triple agonist harder than the injections in c/retatrutide · 298 points · 1 year ago
Right, and it bears repeating that nothing here is approved anywhere and research material is not for human use.
Disagree with this specific inference. A 48-week readout does not tell you the shape of the curve after it.
comment on am I the only one who found triple agonist harder than the injections in c/retatrutide · 112 points · 1 year ago
Correction: TRIUMPH is the phase 3 programme. The number you are quoting is from the phase 2 readout, which is a different trial.
Slightly embarrassed to be asking this, but: am I the only one who found triple agonist harder than the injections. Stopped at a low step because there was no reason to…
comment on reading resistance training threads from 2024 and half of it aged badly in c/glp1muscle · 31 points · 1 year ago
Correction: those scans are from different machines, and the difference you are describing is within the measurement error.
comment on switched from 0.5mg to 1.0mg and early fullness got better, not worse in c/tapering · 1 points · 1 year ago
How long were you at the dose you are coming off?
comment on [Results] 44 weeks on 12.5mg, full numbers, ask me anything boring in c/glp1muscle · 9 points · 1 year ago
losing weight slower does not automatically preserve more lean mass
comment on [Discussion] the related substances advice in here is 2 years out of date in c/coa · 0 points · 1 year ago
I would not read a rounded figure as evasive. Plenty of documents round to one decimal as house style.
comment on [Lab] split one vial across Janoshik and Medutest — 98.1% and 97.6% in c/coa · 3 points · 1 year ago
Asked GGPeps for the batch-specific certificate and had the full document — batch, date, method line naming the column — inside six hours. That is now my baseline for everybody.
comment on [Lab] split one vial across Janoshik and Medutest — 98.1% and 97.6% in c/coa · 12 points · 1 year ago
Agreed — the itemised related substances table is the difference between a document and a receipt.
comment on [Discussion] can we stop arguing about reconstitution until somebody posts a number in c/reconstitution · 45 points · 1 year ago
Careful — that arithmetic is wrong. 15mg in 2mL is 7.5mg/mL, so 0.75mg draws to 10 units, not what you wrote.